Get the Stockscreener App
5.43
7.50%
-0.44
After Hours:
5.40
-0.03
-0.55%
Myomo Inc stock is traded at $5.43, with a volume of 979.12K.
It is down -7.50% in the last 24 hours and down -13.67% over the past month.
Myomo, Inc., a commercial stage medical robotics company, designs, develops, and produces myoelectric braces or orthotics for people suffering with neuromuscular disorders in the United States. It offers MyoPro, a powered upper limb orthosis that supports the arm, as well as restores function to the weakened or paralyzed arms of patients suffering from CVA stroke, brachial plexus injury, traumatic brain injury, spinal cord injury, ALS, or other neuromuscular disease or injury. The company serves orthotics and prosthetics practices or clinics, as well as the veteran administration and other hospitals through orthotics and prosthetics providers, and distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Cambridge, Massachusetts.
See More
Previous Close:
$5.87
Open:
$6.05
24h Volume:
979.12K
Relative Volume:
2.15
Market Cap:
$182.97M
Revenue:
$25.24M
Net Income/Loss:
$-8.38M
P/E Ratio:
-23.61
EPS:
-0.23
Net Cash Flow:
$-9.54M
1W Performance:
+16.03%
1M Performance:
-13.67%
6M Performance:
+32.44%
1Y Performance:
+42.89%
1-Day Range:
$5.365
$6.05
1-Week Range:
$4.12
$6.2996
52-Week Range:
$2.5108
$7.1699
Myomo Inc Stock (MYO) Company Profile
Name
Myomo Inc
Sector
Industry
Phone
617-996-9058
Address
One Broadway, 14th Floor, Cambridge, MA
Compare MYO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MYO
Myomo Inc
|
5.43 | 182.97M | 25.24M | -8.38M | -9.54M | -0.23 |
|
ABT
Abbott Laboratories
|
130.28 | 225.95B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
96.42 | 142.29B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
363.84 | 138.83B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
91.51 | 117.34B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
68.51 | 40.28B | 5.72B | 4.17B | 259.90M | 6.97 |
Myomo Inc Stock (MYO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-31-24 | Initiated | Craig Hallum | Buy |
| May-20-24 | Initiated | Lake Street | Buy |
| Dec-15-23 | Initiated | H.C. Wainwright | Buy |
| Nov-11-20 | Upgrade | ROTH Capital | Neutral → Buy |
| May-27-20 | Initiated | Dougherty & Company | Buy |
| Oct-02-17 | Initiated | H.C. Wainwright | Buy |
View All
Myomo Inc Stock (MYO) Latest News
Myomo stock price target raised to $9.50 by H.C. Wainwright - Investing.com India
Myomo’s Strong Financial Performance and Promising Growth Prospects Drive Buy Rating - TipRanks
Myomo price target raised to $9.50 from $7.50 at H.C. Wainwright - TipRanks
Craig Hallum Issues Positive Forecast for Myomo (NYSEAMERICAN:MYO) Stock Price - Defense World
Myomo Inc. Reports Record Growth Amid Challenges - TipRanks
Myomo price target raised to $11 from $9 at Craig-Hallum - TipRanks
Myomo, Inc. (AMEX:MYO) Q4 2024 Earnings Call Transcript - Insider Monkey
Myomo’s revenue jumps 154% to USD 12.1M in Q4 2024 - Medical Buyer
Myomo Inc (MYO) Q4 2024 Earnings Call Highlights: Record Revenue Growth and Strategic Market ... - Yahoo Finance
Myomo Reports Record Revenue and Positive Cash Flow - TipRanks
Earnings call transcript: Myomo Q4 2024 beats forecasts, shares surge By Investing.com - Investing.com Australia
Myomo earnings beat by $0.01, revenue topped estimates - Investing.com India
Earnings call transcript: Myomo Q4 2024 beats forecasts, shares surge - Investing.com India
Myomo, Inc. (MYO) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance
Myomo Q4 Loss Narrows, Sales Rise; Sets Guidance -March 10, 2025 at 04:57 pm EDT - Marketscreener.com
Myomo stock soars 15.8% on strong Q4 results, upbeat 2025 outlook By Investing.com - Investing.com South Africa
Myomo stock soars 15.8% on strong Q4 results, upbeat 2025 outlook - Investing.com Australia
Myomo reports Q4 EPS (1c), consensus (2c) - TipRanks
Myomo's Fourth Quarter Financial Results Feature Record Revenue of $12.1 Million - The Bakersfield Californian
What To Expect From Myomo Inc (MYO) Q4 2024 Earnings - GuruFocus.com
Myomo, Inc. to Host Earnings Call - ACCESS Newswire
Myomo to Report Fourth Quarter 2024 Financial Results on March 10 - Joplin Globe
When Will Myomo Report Q4 Results? Key Date for MYO Investors Announced - StockTitan
Myomo (MYO) Projected to Post Earnings on Thursday - Defense World
Learn to Evaluate (MYO) using the Charts - Stock Traders Daily
Myomo secures $3M term loan, amends credit line By Investing.com - Investing.com Canada
Myomo secures $3M term loan, amends credit line - Investing.com
A Look at Myomo Inc (MYO) Shares in the Recent Past Indicates Growth - SETE News
Legato Capital Management LLC Reduces Position in Myomo, Inc. (NYSEAMERICAN:MYO) - MarketBeat
Stratos Wealth Partners LTD. Sells 25,000 Shares of Myomo, Inc. (NYSEAMERICAN:MYO) - Defense World
MYO (Myomo Inc) may reap gains as insiders became active recently - Knox Daily
Rosalind Advisors, Inc. Increases Stake in Myomo Inc. - GuruFocus.com
Former Medtronic Pelvic Health President Joins Inogen Board: Strategic Move in Respiratory Care Leadership - StockTitan
3 Underrated Robotics Stocks Poised for Major Growth - MarketBeat
Barclays PLC Makes New Investment in Myomo, Inc. (NYSEAMERICAN:MYO) - Defense World
Revisiting Myomo: Valuation Reflects High Growth, But Execution Matters (NYSE:MYO) - Seeking Alpha
Jane Street Group LLC Buys Shares of 16,140 Myomo, Inc. (NYSEAMERICAN:MYO) - Defense World
Erland Construction Completes State-of-the-Art Facility for Myomo at 45 Blue Sky Drive - Boston Real Estate Times
When (MYO) Moves Investors should Listen - Stock Traders Daily
Geode Capital Management LLC Sells 3,280 Shares of Myomo, Inc. (NYSEAMERICAN:MYO) - Defense World
Barclays PLC Takes Position in Myomo, Inc. (NYSEAMERICAN:MYO) - Defense World
Myomo stock hits 52-week high at $6.88 amid robust growth - Investing.com Australia
Where are the Opportunities in (MYO) - Stock Traders Daily
Top 3 Cutting-Edge Micro-Caps Set for 2025 Growth - The Globe and Mail
Craig Hallum Forecasts Strong Price Appreciation for Myomo (NYSEAMERICAN:MYO) Stock - Defense World
Myomo dips on $15M equity offering - MSN
Myomo stock soars to 52-week high, hits $6.4 amid robust gains - Investing.com Canada
(MYO) Technical Pivots with Risk Controls - Stock Traders Daily
Myomo stock soars to 52-week high, hits $6.4 amid robust gains By Investing.com - Investing.com South Africa
Myomo to sell shares of common stock in underwritten public offering - Medical Buyer
Myomo Inc Stock (MYO) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.08%
0.71%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):